These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19226288)

  • 1. Pharmacokinetics of oltipraz in diabetic rats with liver cirrhosis.
    Ahn CY; Bae SK; Bae SH; Kim T; Jung YS; Kim YC; Lee MG; Shin WG
    Br J Pharmacol; 2009 Mar; 156(6):1019-28. PubMed ID: 19226288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic interaction between oltipraz and omeprazole in rats: Competitive inhibition of metabolism of oltipraz by omeprazole via CYP1A1 and 3A2, and of omeprazole by oltipraz via CYP1A1/2, 2D1/2, and 3A1/2.
    Lee DY; Kim JW; Lee MG
    Eur J Pharm Sci; 2007 Dec; 32(4-5):328-39. PubMed ID: 17935951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic changes of oltipraz after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine.
    Bae SK; Lee SJ; Lee JY; Lee Y; Lee I; Kim SG; Lee MG
    Int J Pharm; 2004 May; 275(1-2):227-38. PubMed ID: 15081153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of oltipraz in rat models of diabetes mellitus induced by alloxan or streptozotocin.
    Bae SK; Kim JY; Yang SH; Kim JW; Kim T; Lee MG
    Life Sci; 2006 Apr; 78(20):2287-94. PubMed ID: 16288785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of oltipraz in mutant Nagase analbuminemic rats.
    Bae SK; Kang HE; Kang MK; Kim JW; Kim T; Lee MG
    J Pharm Sci; 2006 May; 95(5):998-1005. PubMed ID: 16544321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of enzyme inducers and inhibitors on the pharmacokinetics of oltipraz in rats.
    Bae SK; Lee SJ; Kim YH; Kim T; Lee MG
    J Pharm Pharmacol; 2005 Apr; 57(4):443-52. PubMed ID: 15831204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cysteine on the pharmacokinetics of oltipraz in rats with protein-calorie malnutrition.
    Bae SK; Yang SH; Kim JW; Kim T; Kwon JW; Lee MG
    J Pharm Sci; 2005 Jul; 94(7):1484-93. PubMed ID: 15920769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and therapeutic effects of oltipraz after consecutive or intermittent oral administration in rats with liver cirrhosis induced by dimethylnitrosamine.
    Bae SK; Lee SJ; Kim T; Kim JW; Lee I; Kim SG; Lee MG
    J Pharm Sci; 2006 May; 95(5):985-97. PubMed ID: 16544323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of sildenafil and its metabolite, N-desmethylsildenafil, in rats with liver cirrhosis and diabetes mellitus, alone and in combination.
    Ahn CY; Bae SK; Bae SH; Kang HE; Kim SH; Lee MG; Shin WG
    Xenobiotica; 2011 Feb; 41(2):164-74. PubMed ID: 21070144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats with diabetes mellitus.
    Ahn CY; Bae SK; Jung YS; Lee I; Kim YC; Lee MG; Shin WG
    Drug Metab Dispos; 2008 Jul; 36(7):1233-41. PubMed ID: 18378564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic changes of drugs in a rat model of liver cirrhosis induced by dimethylnitrosamine, alone and in combination with diabetes mellitus induced by streptozotocin.
    Lee U; Oh E
    Biopharm Drug Dispos; 2015 Jan; 36(1):1-14. PubMed ID: 24861008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.
    Kensler TW; Egner PA; Dolan PM; Groopman JD; Roebuck BD
    Cancer Res; 1987 Aug; 47(16):4271-7. PubMed ID: 2886217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of oltipraz and its major metabolite (RM) in patients with liver fibrosis or cirrhosis: relationship with suppression of circulating TGF-beta1.
    Kim SG; Kim YM; Choi YH; Lee MG; Choi JY; Han JY; Cho SH; Jang JW; Um SH; Chon CY; Lee DH; Jang JJ; Yu ES; Lee YS
    Clin Pharmacol Ther; 2010 Sep; 88(3):360-8. PubMed ID: 20664537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of omeprazole after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine.
    Lee DY; Lee I; Lee MG
    Int J Pharm; 2007 Feb; 330(1-2):37-44. PubMed ID: 16997515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oltipraz regenerates cirrhotic liver through CCAAT/enhancer binding protein-mediated stellate cell inactivation.
    Kang KW; Kim YG; Cho MK; Bae SK; Kim CW; Lee MG; Kim SG
    FASEB J; 2002 Dec; 16(14):1988-90. PubMed ID: 12397085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of dimethylnitrosamine-induced liver fibrosis by [5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione] (oltipraz) in rats: suppression of transforming growth factor-beta1 and tumor necrosis factor-alpha expression.
    Kang KW; Choi SH; Ha JR; Kim CW; Kim SG
    Chem Biol Interact; 2002 Jan; 139(1):61-77. PubMed ID: 11803029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1 and 3A1/2 for the metabolism of metformin.
    Choi YH; Lee MG
    Br J Pharmacol; 2006 Oct; 149(4):424-30. PubMed ID: 16940989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz.
    Buetler TM; Gallagher EP; Wang C; Stahl DL; Hayes JD; Eaton DL
    Toxicol Appl Pharmacol; 1995 Nov; 135(1):45-57. PubMed ID: 7482539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism.
    Yang KH; Choi YH; Lee U; Lee JH; Lee MG
    J Pharm Pharmacol; 2009 Jan; 61(1):47-54. PubMed ID: 19126296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of diabetes mellitus induced by alloxan on the pharmacokinetics of metformin in rats: restoration of pharmacokinetic parameters to the control state by insulin treatment.
    Lee MG; Choi YH; Lee I
    J Pharm Pharm Sci; 2008; 11(1):88-103. PubMed ID: 18445367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.